industry
Dentistry’s new arms race: capturing intent, not building trust
From 90-day “demand capture” playbooks to Turkey-teeth pipelines and electrified toothbrushes, the industry is reorganising around conversion speed—with clinical risk trailing behind.
By Brad Newman ·

Dentistry used to sell time. Not chair time—trust time. The old playbook was local reputation, word-of-mouth, a few decades of the same hygienist, and a practice sign that never changed. Now it sells something else: speed. Speed to the click, speed to the consult, speed to the veneer, speed to the implant, speed to the before-and-after. You can see it in the cheery practicality of the new “First 90 Days Demand Capture” plan for a new office: don’t romanticise “brand building,” it says—stand up tracking, buy high-intent search, measure calls, convert into booked patients. The message is refreshingly candid and also a little damning. We are no longer pretending the practice is a community institution first. It is a funnel.
The non-obvious trend tying this week’s grab-bag of headlines together is that dentistry is converging on the same operating model as the rest of consumer healthcare: intent harvesting. This is not “marketing,” in the genteel sense. It’s industrialised conversion—structured around attribution, lead velocity, and unit economics. The demand-capture advocates are explicit: in a defined trade area, there is already existing intent, and your job is to capture it with a measurable system. That’s the same logic powering the “Turkey teeth” phenomenon in the UK, where private actors fill gaps left by an overstretched NHS by packaging smile makeovers as a product with a timeline. It’s the same logic behind holiday-season product roundups that turn mouthwash and breath sprays into stocking fillers. And it’s even the logic behind the electricity-generating toothbrush story: prevention, repackaged as a tech feature you can buy, not a habit you patiently cultivate.
The uncomfortable question for industry insiders is what happens when the funnel outpaces the physiology. Consider the implant-planning angle from VNDentalTravel, which puts bite relationships at the centre of planning. That sounds clinical—and it is—but it’s also commercial. Bite is the unsexy thing that ruins glossy outcomes. Occlusal scheme, vertical dimension, parafunctional habits: these don’t fit in an Instagram carousel, but they determine whether an all-on-X case feels miraculous or becomes a litigation file. Dental travel businesses have learned, sometimes the hard way, that you cannot simply “place teeth” and call it dentistry. You have to engineer function. That’s not altruism; it’s risk management in a business model where patients are geographically distant, follow-up is constrained, and reputational blowback travels faster than the patient. Bite relationships become a selling point precisely because the market has been burned by outcomes that were cosmetically acceptable and biomechanically doomed.
Materials science is facing the same tension between sellable novelty and slow evidence. The Cureus review on polymer-infiltrated ceramic networks—hybrid ceramics—reads like an academic counterweight to the industry’s love of “new.” PICN materials promise a Goldilocks profile: ceramic-like aesthetics with polymer-like resilience, potentially kinder to opposing dentition and less brittle than traditional ceramics. That’s the pitch, and it’s plausible. But the market often behaves as though plausibility is proof. In reality, the difference between a promising chairside material and a reliable standard of care is years of clinical data, not a manufacturer’s brochure and a handful of in vitro studies. Hybrid ceramics live in a crowded field that already includes lithium disilicate, zirconia in multiple generations, and resin nanoceramics—each with its own failure modes, bonding requirements, and long-term uncertainties. When you combine that complexity with a demand-capture engine that rewards immediate case acceptance, you get a predictable pathology: clinicians pressured—by competition, by production goals, by patient expectations—to choose the material that sells, not the one with the longest track record for that occlusal scenario.
This is where the electricity-generating toothbrush and the tooth-loss/dementia linkage stop being “soft” news and start being strategic. If tooth loss is even directionally associated with dementia risk in older adults—a relationship that research has explored through inflammation, nutrition, and social determinants—then dentistry’s impact perimeter expands dramatically. It’s no longer just aesthetics and mastication; it’s cognitive ageing, quality of life, and health system cost. That should be a gift to the profession: a stronger prevention narrative, more integration with primary care, more reimbursement logic. Instead, what the market often does is weaponise the association as an anxiety lever. Prevention becomes a product category, and product categories become content mills: gadget toothbrushes that “reduce harmful bacteria” through self-generated electricity; tabloid product tests promising a “fresh mouth for the holiday season.” None of this is inherently bad—consumer engagement is good—but it reveals the same structural move: oral health reframed as a retail experience, mediated by claims that travel faster than clinical nuance.
The practice-level economics make this drift almost inevitable. A new dentist joining a local practice—like Dr. Adam Hildebrandt at Dental Arts in Amery—used to be a story about access, continuity, maybe succession planning. In 2026, it’s also a story about capacity utilisation. If you can add a provider, you can extend hours, shorten wait times, and, crucially, buy more demand-capture without breaking the schedule. Digital marketing isn’t cheap anymore, not if you’re doing it seriously. In many US markets, high-intent search terms—“emergency dentist,” “same-day crown,” “dental implants near me”—can run into double-digit cost-per-clicks, and that’s before you pay for call tracking, landing pages, and someone to answer the phone like they mean it. The “90 days” framing is an investor’s framing: ramp fast, measure everything, iterate weekly. It borrows from SaaS, but with a twist: the conversion is a human being who will sit in a chair and accept irreversible treatment.
The industry’s favourite retort is that none of this is new; dentists have always marketed, and patients have always shopped. True—and incomplete. What’s new is the precision and the speed. Tracking numbers, keyword-level attribution, call recording, automated follow-up texts, online scheduling, review-generation prompts: the practice can now run like a performance marketing shop. The KPI is no longer “new patients per month” in the abstract; it’s cost per booked call, show rate, case acceptance rate by procedure, and lifetime value. That creates a gravitational pull toward treatments that monetise well and market well. Implants, aligners, veneers, whitening—high-ticket, high-visual. Prevention and periodontal maintenance, by contrast, are slow, recurring, and hard to glamorise. Yet those “boring” services are the ones most plausibly connected to systemic outcomes like tooth retention and, potentially, cognitive health trajectories. The funnel rewards the photogenic; biology rewards the mundane.
And yet, there’s a countercurrent in these same headlines: function is staging a comeback, not because the profession has discovered humility, but because the marketplace is discovering consequences. VNDentalTravel’s emphasis on bite relationships is a signal that the veneer/implant industrial complex is learning what prosthodontists have been saying for decades: occlusion is not optional. Hybrid ceramics are popular because they promise a compromise between beauty and durability—an implicit admission that pure aesthetics can be mechanically unforgiving. Even the electric toothbrush story is, in its own way, an acknowledgement that the next competitive frontier is not another shade tab but measurable microbiological impact. The problem is that the marketing machine treats these as features, while clinical reality treats them as constraints.
So what should insiders do with this? First, stop pretending demand capture is merely “marketing support.” It is clinical governance by another name. If you are going to engineer a high-velocity funnel, you must engineer the downstream guardrails with equal seriousness: occlusal diagnostics, material selection protocols, informed consent that actually informs, and post-op follow-up that isn’t sacrificed to keep the schedule open for the next booked call. Second, practices should treat evidence as a strategic asset. If you are going to place hybrid ceramics, have a written decision tree: indications, bonding system, occlusal design, parafunction screening, and a clear explanation of long-term uncertainty. If you are going to sell implants aggressively, bake in bite analysis and maintenance from day one, not as an upsell after complications. Third, the profession should be wary of letting consumer tech and tabloid retail content become the public’s primary oral health curriculum. The dementia link, whether ultimately causal or correlational, is a chance to elevate prevention and periodontal care—if dentistry can resist turning it into a fear-based conversion hook.
The hardest truth is this: capturing intent is now table stakes, but trust is still the only defensible moat. Funnels can be copied. Keywords can be bid up. Dental tourism can arbitrage costs until the next regulatory or reputational shock. What cannot be commoditised—at least not for long—is predictable functional outcomes over five to ten years, delivered with transparent evidence and disciplined case selection. Dentistry is drifting toward the logic of consumer commerce, where the winner is the fastest converter. The winners in the next cycle will be the ones who build conversion engines that are constrained by biology, not merely powered by it. In an era of demand capture, the ethical practice is the one that can say “no” as efficiently as it says “booked.”